DexCom Goodwill and Intangible Assets 2010-2024 | DXCM
DexCom goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- DexCom goodwill and intangible assets for the quarter ending December 31, 2024 were $0.126B, a 20.98% decline year-over-year.
- DexCom goodwill and intangible assets for 2024 were $0.126B, a 20.98% decline from 2023.
- DexCom goodwill and intangible assets for 2023 were $0.16B, a 19.75% decline from 2022.
- DexCom goodwill and intangible assets for 2022 were $0.199B, a 243.1% increase from 2021.
| DexCom Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $126 |
| 2023 | $160 |
| 2022 | $199 |
| 2021 | $58 |
| 2020 | $41 |
| 2019 | $19 |
| 2018 | $19 |
| 2017 | $12 |
| 2016 | $11 |
| 2015 | $6 |
| 2014 | $6 |
| 2013 | $7 |
| 2012 | $7 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| DexCom Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $126 |
| 2024-09-30 | $130 |
| 2024-06-30 | $138 |
| 2024-03-31 | $147 |
| 2023-12-31 | $160 |
| 2023-09-30 | $170 |
| 2023-06-30 | $180 |
| 2023-03-31 | $189 |
| 2022-12-31 | $199 |
| 2022-09-30 | $49 |
| 2022-06-30 | $54 |
| 2022-03-31 | $58 |
| 2021-12-31 | $58 |
| 2021-09-30 | $24 |
| 2021-06-30 | $19 |
| 2021-03-31 | $19 |
| 2020-12-31 | $41 |
| 2020-09-30 | $19 |
| 2020-06-30 | $19 |
| 2020-03-31 | $19 |
| 2019-12-31 | $19 |
| 2019-09-30 | $18 |
| 2019-06-30 | $19 |
| 2019-03-31 | $19 |
| 2018-12-31 | $19 |
| 2018-09-30 | $18 |
| 2018-06-30 | $12 |
| 2018-03-31 | $12 |
| 2017-12-31 | $12 |
| 2017-09-30 | $12 |
| 2017-06-30 | $12 |
| 2017-03-31 | $11 |
| 2016-12-31 | $11 |
| 2016-09-30 | $13 |
| 2016-06-30 | $14 |
| 2016-03-31 | $6 |
| 2015-12-31 | $6 |
| 2015-09-30 | $6 |
| 2015-06-30 | $6 |
| 2015-03-31 | $6 |
| 2014-12-31 | $6 |
| 2014-09-30 | $6 |
| 2014-06-30 | $7 |
| 2014-03-31 | $7 |
| 2013-12-31 | $7 |
| 2013-09-30 | $7 |
| 2013-06-30 | $7 |
| 2013-03-31 | $7 |
| 2012-12-31 | $7 |
| 2012-09-30 | $7 |
| 2012-06-30 | $8 |
| 2012-03-31 | $8 |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $32.004B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||